Class Information

STI Expert Hour Webinar - Urogenital Gonorrhea

May 15, 2026

12:00PM-1:15PM (PDT)

1.25 CME units at no cost

Registration closes on May 14, 2026 at 3:00PM (PDT)

 

 

Course Description 

The FDA has recently approved two new oral treatments for urogenital gonorrhea. But what is the data behind these approvals, and what does this mean for clinical practice? Come join this STI expert hour to learn more!

 

Presenter

Katherine Yang, Pharm.D., MPH

Professor, Department of Clinical Pharmacy, University of California (UCSF) School of Pharmacy

Infectious Diseases Clinical Pharmacist, UCSF Medical Center

 

Learning Objectives

• Describe the mechanisms of action and antimicrobial activity of zoliflodacin and gepotidacin against Neisseria gonorrhoeae, including their effectiveness against drug-resistant strains
• Compare the clinical efficacy, safety profiles, and potential roles of zoliflodacin and gepotidacin in the treatment of gonorrhea

 

Registration Confirmation with Zoom Webinar Link

• Within 24 hours of registering, you will receive a registration confirmation from training@nnptc.org to the email address you used to register for the webinar on NNPTC.

• NOTE: The NNPTC registration confirmation includes the Zoom webinar link. Please review the Zoom webinar link instructions and other webinar details prior to joining the webinar.

• We ask that you do not share or forward any links associated with the webinar.

• Those not registered on NNPTC who sign on to the webinar will not be counted in attendance or eligible to receive CME credit. 

• To ensure you receive the NNPTC registration confirmation, please add training@nnptc.org to your safe/trusted senders list and be sure to monitor both your Inbox and spam/junk folders for the notification.

 

ACCME Disclosure

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nevada, Reno School of Medicine and California Prevention Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians. The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement. Nurses should check with their individual licensing boards to confirm the acceptability of AMA credits for the purpose of licensing renewal.

 

Financial Disclosure

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of a continuing medical education activity disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.

Elizabeth Olson 415-353-8688 elizabeth.olson@ucsf.edu